KR0173084B1 - Method for the purification of triamine compound - Google Patents

Method for the purification of triamine compound Download PDF

Info

Publication number
KR0173084B1
KR0173084B1 KR1019960010835A KR19960010835A KR0173084B1 KR 0173084 B1 KR0173084 B1 KR 0173084B1 KR 1019960010835 A KR1019960010835 A KR 1019960010835A KR 19960010835 A KR19960010835 A KR 19960010835A KR 0173084 B1 KR0173084 B1 KR 0173084B1
Authority
KR
South Korea
Prior art keywords
purification
toluene
inorganic salt
sodium
structural formula
Prior art date
Application number
KR1019960010835A
Other languages
Korean (ko)
Other versions
KR970069976A (en
Inventor
정원교
조군호
이재철
사종신
Original Assignee
성재갑
주식회사엘지화학
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 성재갑, 주식회사엘지화학 filed Critical 성재갑
Priority to KR1019960010835A priority Critical patent/KR0173084B1/en
Publication of KR970069976A publication Critical patent/KR970069976A/en
Application granted granted Critical
Publication of KR0173084B1 publication Critical patent/KR0173084B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/82Purification; Separation; Stabilisation; Use of additives
    • C07C209/84Purification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

본 발명은 하기 구조식(Ⅰ)로 표시되는 1,17-디아미노-9-아자헵타데칸의 정제 방법에 관한 것이다.The present invention relates to a method for purifying 1,17-diamino-9-azaheptadecane represented by the following structural formula (I).

Description

트리아민 화합물의 정제 방법Purification Method of Triamine Compound

본 발명은 트리아민 화합물의 정제 방법에 관한 것으로, 보다 구체적으로는 하기 구조식(Ⅰ)로 표시되는 1,17-디아미노-9-아자헵타데칸의 정제 방법에 관한 것이다.The present invention relates to a method for purifying a triamine compound, and more particularly, to a method for purifying 1,17-diamino-9-azaheptadecane represented by the following structural formula (I).

상기 구조식(Ⅰ)의 화합물은 사과의 검은 별무늬병, 포도의 회색 곰팡이병, 복숭아의 잿빛 무늬병 등의 방제에 유용한 살균제로 잘 알려진 하기 구조식(Ⅱ)로 표기되는 1,1`-아미노디(옥타메틸렌)디구아니디움 트리아세테이트의 합성 중간체로서, 하기 구조식(Ⅲ)으로 표시되는 옥타메틸렌디아민을 산촉매하에서 반응시켜 제조된다.The compound of formula (I) is 1,1`-aminodi represented by the following structural formula (II), which is well known as a fungicide useful for controlling black star pattern disease of apples, gray mold disease of grapes, gray ash pattern of peach, etc. As a synthetic intermediate of octamethylene) diguanidium triacetate, it is prepared by reacting octamethylenediamine represented by the following structural formula (III) under an acid catalyst.

그런데 이 반응은 구조식(Ⅲ)의 아량체인 구조식(Ⅰ)뿐만 아니라 삼량체인 하기 구조식(Ⅳ)를 포함한 다른 부생성물도 생성되기 때문에 구조식(Ⅰ)의 정제 방법은 매우 중요하다.However, since the reaction generates not only Structural Formula (I), which is a submer of Structural Formula (III), but also other by-products including the following Structural Formula (IV), which is a trimer, the purification method of Structural Formula (I) is very important.

예컨대, 유럽 특허공고 제013554호에는 상기 구조식(Ⅰ)의 화합물은 감압증류로 정제되고 있으나, 이의 끓는점과 녹는점이 높기 때문에 증류할 때 높은 온도와 고진공이 필요하고, 여타의 문제점을 수반하고 있어 공업적인 방법으로서는 미흡한 점이 많다.For example, in European Patent Publication No. 013554, the compound of formula (I) is purified by distillation under reduced pressure, but since its boiling point and melting point are high, distillation requires high temperature and high vacuum, and it is accompanied by other problems. There are many inadequate methods.

즉, 상기 특허공고의 정제 방법 중 하나는 구조식(Ⅰ)화합물의 높은 끓는점 때문에 190~220℃의 온도, 4mmHg의 압력에서 구조식(Ⅰ)의 화합물을 고온 감압증류하여 정제하기 때문에 고진공장치와 고온 반응기 장치가 필요하고, 또한 구조식(Ⅰ)의 화합물의 높은 녹는점 때문에 증류관 및 여러 설비의 보온 장치가 필요한 단점이 있다.That is, one of the methods for purifying the patent publication is a high vacuum apparatus and a high temperature reactor because the high boiling point of the compound of formula (I) is purified by distillation of the compound of formula (I) at high temperature under reduced pressure at a temperature of 190-220 ° C. and a pressure of 4 mmHg. An apparatus is required, and due to the high melting point of the compound of formula (I), a distillation tube and a thermostat of various equipment are required.

이에 본 발명자들은 전술한 공지의 방법에 따른 문제점을 해결하고 보다 적합한 정제방법을 찾기 위하여 연구를 하던 중, 유기용매 하에서 용해도 차이와 일반적으로 사용되는 무기염을 이용하여 목적화합물을 높은 수율로 제조할 수 있다는 놀라운 사실을 밝혀내고 본 발명을 완성하게 되었다.Therefore, the present inventors have been researching to solve the problems according to the above-mentioned known methods and to find a more suitable purification method, and to prepare the target compound in high yield using the difference in solubility and the inorganic salts generally used in organic solvents. It has been found that the surprising fact that it can be completed to complete the present invention.

본 발명은 불순한 트리아민(트리/테트라=80/20)을 톨루엔에 가하고 가열하여 완전히 용해시킨 후, 무기염을 가하고, 생성된 테트라민 고체를 여과에 의해 제거하여 하기 구조식(Ⅰ)의 1,17-디아미노-9-아자헵타데칸을 정제하는 방법에 관한 것이다.In the present invention, impure triamine (tri / tetra = 80/20) is added to toluene, heated to completely dissolve it, and then an inorganic salt is added, and the resulting tetramine solid is removed by filtration to obtain 1, the following structural formula (I). A method for purifying 17-diamino-9-azaheptadecane.

이하 본 발명의 정제방법을 상세히 설명한다.Hereinafter, the purification method of the present invention will be described in detail.

본 발명은 하기 구조식(Ⅰ)로 표기되는 트리아민의 정제방법을 유기용매의 용해도 차이와 불순물의 결정성을 돕는 일반적인 무기염을 이용한다.The present invention utilizes a general inorganic salt which helps the triamine represented by the following structural formula (I) to assist in the solubility difference of the organic solvent and the crystallinity of impurities.

불순한 트리아민(트리/테트라=80/20)을 적당량의 톨루엔에 넣고 가열하여 완전히 용해시키고, 서서히 냉각시켜 생성된 불순물(테트라)을 여과하여 제거한다.Impure triamine (tri / tetra = 80/20) is placed in an appropriate amount of toluene, heated to complete dissolution, and gradually cooled to remove impurities (tetra) produced by filtration.

이 때 일반적인 무기염을 첨가하여 불순물의 결정화를 높이는 촉매로 사용한다.At this time, it is used as a catalyst to increase the crystallization of impurities by adding a general inorganic salt.

본 발명에 따른 유기용매로는 톨루엔이 사용되며 톨루엔의 양은 정제전 하기식(Ⅰ)과의 혼합물을 기준으로 하여 4~10배의 중량비로 사용하며, 바람직하게는 5~7배의 중량비로 사용한다.Toluene is used as the organic solvent according to the present invention, and the amount of toluene is used in a weight ratio of 4 to 10 times based on the mixture with the following formula (I) before purification, preferably in a weight ratio of 5 to 7 times. do.

무기염은 염화나트륨, 브롬화나트륨, 질산나트륨, 탄산나트륨, 황산나트륨, 염화나트륨, 염화칼륨 등이 사용될 수 있으나, 특히 좋기로는 염화나트륨 또는 질산나트륨이 바람직하다. 사용되는 무기염의 양은 유기용매의 0.3~3.0%로 하며 바람직하게는 0.5~1.5%로 한다.The inorganic salt may be sodium chloride, sodium bromide, sodium nitrate, sodium carbonate, sodium sulfate, sodium chloride, potassium chloride and the like, but sodium chloride or sodium nitrate is particularly preferred. The amount of the inorganic salt used is 0.3 to 3.0% of the organic solvent, preferably 0.5 to 1.5%.

정제는 20~40℃의 온도 범위에서 수행될 수 있으나, 바람직하게는 25~35℃에서 수행하는 것이 바람직하다.Purification may be carried out in a temperature range of 20 ~ 40 ℃, preferably, it is carried out at 25 ~ 35 ℃.

이하, 본 발명을 실시예에 의거 보다 구체적으로 설명한다.Hereinafter, the present invention will be described in more detail with reference to Examples.

[실시예 1]Example 1

트리아민(Ⅰ) 및 테트라민(Ⅳ)혼합물로 부터 순수 트리아민(Ⅰ)의 정제Purification of Pure Triamine (I) from Triamine (I) and Tetramin (IV) Mixtures

톨루엔 150g에 1,17-디아미노-9-아자헵타데칸이 80% 포함되고 구조식(Ⅳ)를 포함한 부성분이 20% 함유된 혼합물 25g을 넣고 교반하면서 온도를 90℃까지 승온하여 용해시킨다. 여기에 염화나트륨 1.0g을 투입하고 30분간 교반한 뒤 온도를 30℃까지 4시간동안 서서히 냉각한다.150 g of toluene was added to 25 g of a mixture containing 80% of 1,17-diamino-9-azaheptadecane and 20% of the subcomponent including Structural Formula (IV). 1.0 g of sodium chloride was added thereto, stirred for 30 minutes, and then slowly cooled to 4 DEG C for 30 hours.

이때 구조식(Ⅳ) 화합물과 다른 부성분이 고체화 되는 것을 확인하고 1시간동안 더 교반한다. 생성된 고체를 여과하여 여과액 톨루엔을 증류하고 목적화합물 19.1g을 흰색 결정으로 얻었다.(수득율:95.5%, 가스크로마토그래피 순도:95.4%)At this time, confirm that the compound of the structural formula (IV) and the other minor components are solidified, and further stirred for 1 hour. The resulting solid was filtered to distill the filtrate toluene to obtain 19.1 g of the target compound as white crystals (yield: 95.5%, gas chromatography purity: 95.4%).

[실시예 2]Example 2

트리아민(Ⅰ) 및 테트라민(Ⅳ)혼합물로 부터 순수 트리아민(Ⅰ)의 정제Purification of Pure Triamine (I) from Triamine (I) and Tetramin (IV) Mixtures

실시예1)과 같은 방법으로 정제하고, 염화나트륨 대신 질산나트륨 1.0g을 사용하여 목적화합물 19.2g을 흰색 결정으로 얻었다.(수득율:96.1%, 가스크로마토그래피 순도:95.8%)Purification was carried out in the same manner as in Example 1, and 1.0 g of sodium nitrate was used instead of sodium chloride to obtain 19.2 g of the target compound as white crystals (yield: 96.1%, gas chromatography purity: 95.8%).

[실시예 3]Example 3

트리아민(Ⅰ) 및 테트라민(Ⅳ)혼합물로 부터 순수 트리아민(Ⅰ)의 정제Purification of Pure Triamine (I) from Triamine (I) and Tetramin (IV) Mixtures

톨루엔 150g에 1,17-디아미노-9-아자헵타데칸이 70% 포함되고 구조식(Ⅳ)를 포함한 부성분이 30% 함유된 혼합물 25g을 넣고 실시예 1)과 같은 방법으로 정제하여 목적화합물 1,17-디아미노-9-아자헵타데칸 16.5g을 흰색 결정으로 얻었다.(수득율:94.3%, 가스크로마토그래피 순도:94.8%)150 g of toluene contains 70 g of 1,17-diamino-9-azaheptadecane and 30 g of a mixture containing 30% of the minor components including Structural Formula (IV), followed by purification in the same manner as in Example 1). 16.5 g of 17-diamino-9-azaheptadecane was obtained as white crystals. (Yield: 94.3%, gas chromatography purity: 94.8%)

Claims (8)

불순한 트리아민(트리/테트라=80/20)을 톨루엔에 가하고 가열하여 완전히 용해시킨후, 무기염을 가하고, 생성된 테트라민 고체를 여과에 의해 제거하여 하기 구조식(Ⅰ)의 1,17-디아미노-9-아자헵타데칸을 정제하는 방법.Impure triamine (tri / tetra = 80/20) was added to toluene and heated to complete dissolution. Then, an inorganic salt was added, and the resulting tetramine solid was removed by filtration to give 1,17-dia of formula (I) Method for Purifying Mino-9-Azaheptadecane. 제1항에 있어서, 톨루엔의 사용양이 정제전 구조식(Ⅰ)과의 혼합물을 기준으로 하여 4~10배의 중량비인 방법.The method according to claim 1, wherein the amount of toluene used is 4 to 10 times by weight based on the mixture with structural formula (I) before purification. 제2항에 있어서, 톨루엔의 사용양이 정제전 구조식(Ⅰ)과의 혼합물을 기준으로 하여 5~7배의 중량비인 방법.The method according to claim 2, wherein the amount of toluene used is 5 to 7 times by weight based on the mixture with the structural formula (I) before purification. 제1항에 있어서, 무기염이 염화나트륨, 브롬화나트륨, 질산나트륨, 탄산나트륨, 황산나트륨, 염화나트륨 또는 염화칼륨인 방법.The method of claim 1 wherein the inorganic salt is sodium chloride, sodium bromide, sodium nitrate, sodium carbonate, sodium sulfate, sodium chloride or potassium chloride. 제1항에 있어서, 무기염의 사용양이 톨루엔의 0.3~3.0%인 방법.The method according to claim 1, wherein the amount of the inorganic salt used is 0.3 to 3.0% of toluene. 제5항에 있어서, 무기염의 사용양이 톨루엔의 0.5~1.5%인 방법.The method according to claim 5, wherein the amount of the inorganic salt used is 0.5 to 1.5% of toluene. 제1항에 있어서, 정제가 20~40℃의 온도 범위에서 수행되는 방법.The method of claim 1 wherein the purification is carried out in a temperature range of 20-40 ° C. 제7항에 있어서, 정제가 25~35℃에서 수행되는 방법.8. The process of claim 7, wherein the purification is carried out at 25-35 ° C.
KR1019960010835A 1996-04-10 1996-04-10 Method for the purification of triamine compound KR0173084B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019960010835A KR0173084B1 (en) 1996-04-10 1996-04-10 Method for the purification of triamine compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019960010835A KR0173084B1 (en) 1996-04-10 1996-04-10 Method for the purification of triamine compound

Publications (2)

Publication Number Publication Date
KR970069976A KR970069976A (en) 1997-11-07
KR0173084B1 true KR0173084B1 (en) 1999-03-30

Family

ID=19455467

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019960010835A KR0173084B1 (en) 1996-04-10 1996-04-10 Method for the purification of triamine compound

Country Status (1)

Country Link
KR (1) KR0173084B1 (en)

Also Published As

Publication number Publication date
KR970069976A (en) 1997-11-07

Similar Documents

Publication Publication Date Title
US5936104A (en) Process for producing 1,2-epoxy-3-amino-4-phenylbutane derivatives
US2528267A (en) Eobeet j
HU189641B (en) Process for preparing l-ascorbic acid
US6197998B1 (en) Process for producing N-glycyltyrosine and its crystal structure
US6143903A (en) Process for the production of enantiomerically-pure azetidine-2-carboxylic acid
KR0173084B1 (en) Method for the purification of triamine compound
EP0155779B1 (en) A method for the optical purification of an optically active 2,2-dimethylcyclopropanecarboxylic acid amide
US5155257A (en) Process for the preparation of acylaminomethanephosphonic acids
US3933902A (en) Method for the optical resolution of DL-αphenylglycine
US3983162A (en) Optical resolution of alkyl esters of DL-phenylalanine
JPH0737440B2 (en) Method for producing sulfonium compound
GB2109369A (en) Process for purifying guanine
US6147215A (en) Process for producing 1-chlorocarbonyl-4-piperidinopiperidine or hydrochloride thereof
US5091540A (en) Process for preparing clotrimazole
CA2280381C (en) Improved process for the production of an n-acyl derivative of o,s-dialkyl phosphoroamidothioate
JP2507505B2 (en) New method for producing cephalosporin derivatives
US3591579A (en) Resolution of amino-caprolactams
EP0179487B1 (en) 2-phenylpropionic acid esters, method for optical resolution thereof and optically active substance thereof
US4211883A (en) Process for the production of p-(N-methyl)-aminobenzoyl-L-glutamic acid
EP0051956B1 (en) Preparation of l-aspartic acid n-thiocarboxyanhydride
JP3815064B2 (en) Method for purifying 1- (4-chlorobenzoyl) -5-methoxy-2-methylindole-3-acetic acid
JPH0948789A (en) Purification of o,s-dimethyl-n-acetylphosphoramidothioate
JPH0446175A (en) Production of 5-hydroxy-3,4-methylenedioxybenzoic acid derivative
JP2773627B2 (en) Process for producing O, O'-diacyltartaric anhydride
JP2001322981A (en) Method for producing n,n'-carbonylbislactam

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20060915

Year of fee payment: 9

LAPS Lapse due to unpaid annual fee